Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Salona Global Medical Device Corporation focuses on developing and manufacturing innovative medical devices, particularly in the orthopedic and surgical sectors. The company operates primarily in North America and has a unique competitive advantage through its proprietary technologies and strategic partnerships with healthcare providers.
Salona generates revenue primarily through the sale of medical devices to hospitals and clinics, leveraging its proprietary technologies to offer superior product performance. The company benefits from strong pricing power due to its innovative offerings and established relationships with healthcare providers.
Regulatory approvals for new medical devices
Partnerships with major healthcare providers
Changes in healthcare reimbursement policies
Market demand for orthopedic and surgical products
Technological disruption from new entrants in the medical device space
Regulatory changes affecting product approvals and market access
Intense competition from established medical device manufacturers
Emerging startups with innovative technologies
High operating losses leading to liquidity concerns
Debt levels that may restrict financial flexibility
moderate - The demand for medical devices is somewhat insulated from economic cycles, but significant downturns can affect hospital budgets and elective procedures.
The company is sensitive to interest rates as higher rates can increase financing costs for expansion and R&D, potentially impacting profitability and valuation multiples.
minimal - Salona does not heavily rely on credit for operations, but access to financing can be impacted by credit market conditions.
growth - Investors looking for high growth potential in the medical device sector may find Salona appealing due to its innovative product pipeline.
high - The stock has exhibited high volatility, reflecting its operational challenges and market sentiment.
